SBI Biotech Co., Ltd.
Records under this name other than the patents SBI Biotech Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 7 of 7 · Back to SBI Biotech Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE48,140 | Furanone derivative Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,475,876 | Anti oncostatin M receptor beta antibody used for treating atopic dermatitis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,030,289 | Oligonucleotide and use thereof Lapsed on the fee record Ended Oct 4, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 4, 2023 | From the USPTO record |
| US 8,742,113 | Furanone derivative Formerly held Surrendered on reissue Surrendered on reissue May 1, 2018 · From the USPTO record | Surrendered on reissue | Surrendered on reissue May 1, 2018 | From the USPTO record |
| US 8,529,896 | ANTI-BST2 Antibody Lapsed on the fee record Ended Sep 10, 2017 · High confidence | Lapsed on the fee record | Ended Sep 10, 2017 | High confidence |
| US 8,435,530 | Methods for suppressing activity of activated interferon-producing cells Lapsed on the fee record Ended May 7, 2017 · From the USPTO record | Lapsed on the fee record | Ended May 7, 2017 | From the USPTO record |
| US 8,119,812 | Thiazolidinone derivative Lapsed on the fee record Ended Feb 21, 2016 · From the USPTO record | Lapsed on the fee record | Ended Feb 21, 2016 | From the USPTO record |